Alesion®

DRUG3 trials

Sponsors

Boehringer Ingelheim

Conditions

Rhinitis, Allergic, PerennialUrticaria

Unknown Phase

Post Marketing Surveillance of Alesion® in Japanese Paediatric Patients With Allergic Rhinitis, Eczema/Dermatitis, Urticaria and Pruritus

CompletedNCT02238236

Boehringer IngelheimRhinitis, Allergic, Perennial

Start: 2005-05-31Updated: 2014-09-12

Study to Investigate the Safety and Efficacy of Alesion® in Japanese Paediatric Patients With Urticaria

CompletedNCT02238249

Boehringer IngelheimUrticaria

Start: 2005-10-31Updated: 2014-09-12

Postmarketing Surveillance to Investigate the Safety and Efficacy Information of Alesion® Tablet

CompletedNCT02238223

Boehringer IngelheimRhinitis, Allergic, Perennial

Start: 2004-04-30Updated: 2014-09-12